Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
5.17
0.00 (0.00%)
Aug 14, 2025, 11:23 AM - Market open
Foghorn Therapeutics Market Cap
Foghorn Therapeutics has a market cap or net worth of $292.26 million as of August 14, 2025. Its market cap has decreased by -21.86% in one year.
Market Cap
292.26M
Enterprise Value
113.34M
1-Year Change
-21.86%
Ranking
Category
Stock Price
$5.17
Market Cap Chart
Since the IPO on October 23, 2020, Foghorn Therapeutics's market cap has decreased from $565.43M to $292.26M, a decrease of -48.31%. That is a compound annual growth rate of -12.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 275.30M | 4.92% |
| Dec 31, 2024 | 262.40M | -3.64% |
| Dec 29, 2023 | 272.30M | 2.10% |
| Dec 30, 2022 | 266.70M | -68.56% |
| Dec 31, 2021 | 848.32M | 17.59% |
| Dec 31, 2020 | 721.42M | 27.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 586.68B |
| Johnson & Johnson | 417.87B |
| AbbVie | 348.95B |
| UnitedHealth Group | 231.12B |
| AstraZeneca | 227.85B |
| Abbott Laboratories | 227.74B |
| Novartis AG | 225.61B |
| Novo Nordisk | 224.34B |